UNIVERSAL ASSEMBLY PLATFORM
LIVE

Serial Number

79416426

Owner

Valink Therapeutics Inc.

Attorney

Matthew A. Homyk

Filing Date

Dec 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

UNIVERSAL ASSEMBLY PLATFORM Trademark

Serial Number: 79416426

UNIVERSAL ASSEMBLY PLATFORM is a trademark filed by Valink Therapeutics Inc. on December 20, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Valink Therapeutics Inc. (5 trademarks)

2261 Market Street #4161

Entity Type: 03

Trademark Details

Filing Date

December 20, 2024

Registration Date

Not Registered

Published for Opposition

April 28, 2026

Goods & Services

Chemicals for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodies, other than for medical use; proteins for binding antibodies, other than for medical use; immunological antibodies, other than for medical use; biological preparations for use in industry and science; chemical preparations for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical preparations for use in the production of drugs; chemicals for use in scientific research, other than medical or veterinary purposes; chemicals for use in biotechnological product development

Scientific and technological services, namely, research and design relating thereto in the fields of pharmaceutical, biomedical, and chemical sciences; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; testing of pharmaceuticals; biochemistry drug services, namely, pharmaceutical drug development services; biotechnology research; biological research, clinical research in the field of radiology and chemotherapy and medical research; research and development in the field of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology research, namely, biotechnology testing; scientific research relating to biotechnology; biochemistry consultancy; biochemistry research services; biochemical research and development; research and development in the field of biotechnology; biochemical engineering services; veterinary research laboratory services; medical research laboratory services; medical research laboratory services relating to pharmaceuticals; providing information relating to scientific research in the fields of biochemistry and biotechnology; consultancy in the field of pharmaceutical research; scientific consultancy in the field of biotechnology; consultancy relating to research and development in the field of therapeutics

Pharmaceuticals and medical preparations for the prevention and treatment of cancer in humans and animals; pharmaceutical drugs for the prevention and treatment of cancer in humans and animals; pharmaceutical preparations for the prevention and treatment of cancer in humans and animals; antibodies for medical purposes; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use for the treatment of cancer

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 2, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 2, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 23, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 2, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 2, 2025 RFRR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 4, 2025 ADCH
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 13, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 12, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 6, 2025 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
May 16, 2025 NREP
CORRECTION TRANSACTION RECEIVED FROM IB
May 9, 2025 CRCV
APPLICATION FILING RECEIPT MAILED
Feb 7, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 6, 2025 REPR